mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
-0.2 |
2e-09 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
8e-07 |
mRNA |
PD-0325901 |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
1e-06 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
2e-06 |
mRNA |
Midostaurin |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
2e-06 |
mRNA |
BRD-K97651142 |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
2e-06 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
2e-06 |
mRNA |
FK866 |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
7e-06 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
8e-06 |
mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
9e-06 |